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Aspergillus infection in a hospitalised
veteran population
The recent article by Paterson [1] provided an
update on the changing nature of infection with
Aspergillus spp., and highlighted the appearance
of this disease in non-conventional hosts. Our
own experience with aspergillosis in a veteran
population hospitalised at the Salem Veterans
Affairs Medical Center also supports a shift in the
nature of the affected patients. Following review
of all inpatients between 1989 and 2003, 17
patients were identified with Aspergillus infection.
The mean age of these patients was 59.8 years, all
were male, 15 were Caucasian and two were
African-American. Thirteen (76%) were smokers.
Concurrent medical illness included chronic
obstructive pulmonary disease in seven patients,
and pre-existing cavitary lung lesions in four.
Two patients had a history of treated tuberculosis.
Only four patients were immunocompromised,
three with AIDS and one with chronic lympho-
cytic leukaemia.
Presenting symptoms were dyspnoea or cough
in nine patients, haemoptysis in three, stroke in
one, and sinusitis in one. Eleven immunocompe-
tent patients had pulmonary involvement (five
patients with Aspergillus pneumonia, with one
complicated by empyema, five cavitary lung
lesions and one isolated Aspergillus empyema).
One immunocompetent patient had invasive max-
illary sinusitis, and one had septic arthritis. One
immunocompromised patient had disseminated
aspergillosis and presented with a posterior cir-
culation stroke, two had pulmonary involvement,
and one had perioral cutaneous spread. Patients
were treated with amphotericin B or triazole
antifungal agents based on the severity of the
disease. The deaths of five patients were related to
Aspergillus infection, but three of these were
identified only at autopsy. Of the latter three
cases, one patient had AIDS, with a stroke result-
ing from vascular invasion, while two deaths were
of immunocompetent patients with pulmonary
aspergillosis.
Aspergillosis as a clinical entity is difficult to
diagnose, and is diagnosed occasionally only at
autopsy. We concur with Dr Paterson’s assess-
ment that a higher index of suspicion is needed to
improve the outcomes for patients with invasive
Aspergillus infection, not only in immunocompro-
mised patients, but also in immunocompetent
hosts.
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